HBOT for Muscle Recovery: What the 2025 Evidence Actually Shows
A 2025 meta-analysis links HBOT to faster recovery from muscle injury, while Cochrane found no clear benefit for soreness. What recovery-chamber buyers can honestly expect.
A 2025 meta-analysis: injury versus soreness
A systematic review and meta-analysis published in 2025 pooled 10 studies with 299 participants to assess hyperbaric oxygen for exercise-induced muscle injury and soreness. It reported that HBOT significantly accelerated recovery from exercise-induced muscle injury (p < .0001). Subgroup analyses suggested the effect was present at both higher (above 2.0 ATA) and lower (2.0 ATA or below) pressures, and at session lengths of 60 and 100 minutes, in both college students and elite athletes.
The same analysis, however, did not find a significant benefit for muscle soreness (p = .54). That split - a signal for measured muscle injury but not for subjective soreness - is the single most important nuance in the recovery conversation. Measured muscle injury and self-rated soreness are related but not identical: markers of muscle damage can settle while an athlete still feels sore, or the reverse.
Cochrane: no clear benefit for DOMS
That nuance lines up with an older Cochrane review, which examined hyperbaric oxygen for delayed-onset muscle soreness (DOMS) and closed soft-tissue injury and concluded there was insufficient evidence to show it was superior to control conditions. The review noted that DOMS trials were consistently negative, and that some even reported higher pain scores 48 and 72 hours after treatment.
A Cochrane finding of 'insufficient evidence' is not the same as 'proven useless', but it does mean the case for HBOT as a soreness remedy has not been made in the data collected so far. The report of higher pain scores in some DOMS trials is a particular caution against assuming a session can only ever help.
A 2025 single-session crossover trial
A 2025 single-blind crossover trial in Frontiers in Sports and Active Living tested one practical scenario: a single 60-minute session at 2.5 ATA after moderate-intensity exercise, compared with mild hyperbaric air, in nine male university students, with perceived fatigue rated on a visual analogue scale.
The authors suggested oxygen may have some effect on perceived fatigue recovery, but concluded that this small study could not determine its efficacy. With only nine participants, it is best read as a pilot signal rather than an answer. A crossover design, in which each person serves as their own control a week apart, is a sensible choice at small scale, but it cannot overcome the basic problem of too few people.
What buyers can honestly expect
Put together, the evidence is genuinely mixed: a meta-analysis pointing to faster recovery from measurable muscle injury, a Cochrane review finding no clear advantage for soreness, and a small trial that is suggestive but inconclusive on fatigue. None of this supports marketing that promises guaranteed recovery gains. If you are shopping for a recovery-oriented device, our overview of low-pressure options at soft-sided chambers can help match realistic expectations to the pressures those units actually deliver, which are lower than several of the study protocols above.
Recovery needs vary from athlete to athlete. Before investing in HBOT for training or rehabilitation, it is worth reviewing your goals and health status with a sports physician who can put these mixed findings in personal context.